Colossal Biosciences is establishing standards for how biotechnology can responsibly support biodiversity conservation in an ...

Doctors have never had so many cholesterol-lowering drugs at their disposal, but getting patients to take them every day is ...

A small group of humans barely rest at night – and never suffer for it. Science is about to find out why that matters for all ...

Murad Mamedov, Ph.D., brings expertise in unique, unconventional T cells to advance new cancer immunotherapies.

What if the biggest winners in biotech weren’t the ones promising miracle cures, but the ones quietly supplying the picks and ...

Synthego, a pioneering leader in genome engineering solutions, today announced that the Supreme Court of the United States has denied a petition for a writ of certiorari from Agilent Technologies, Inc ...

CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...

Professor Emeritus Richard F. Ludueña discusses his novel theoretical framework for cancer chemotherapy, utilising ...

Trace the timeline of CRISPR-Cas9 from its 2012 discovery to the latest AI-driven advancements and "N-of-1" clinical ...

A key cancer-fighting gene in leukemia is switched off—not broken—and scientists from The Jackson Laboratory (JAX) found a ...

CB-011, an allogeneic CAR T product, received RMAT designation as treatment for multiple myeloma based on strong dose ...

CRISPR Therapeutics AG (CRSP) is rated Buy, with a 12-month price target of $64.58, driven by CASGEVY's commercial ramp and a ...